Amneal Pharmaceuticals, Inc.
AMRX
Revenue
695.42M
▼-35.10M▼-4.80%
3 Months ChangeAssets
3.37B
▼-136.20M▼-3.89%
3 Months ChangeLiabilities
0.00
0.000.00%
3 Months ChangeFree Cash Flow
-5.75M
▲7.85M▲57.72%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-01
Form 8-K
ID: 0001628280-24-041646
2024-08-09
Form 10-Q
ID: 0001723128-24-000032
2024-08-09
Form 8-K
ID: 0001723128-24-000030
2024-05-08
Form 10-Q
ID: 0001723128-24-000021
2024-05-07
Form 8-K
ID: 0001628280-24-021107
2024-05-03
Form 8-K
ID: 0001723128-24-000018
2024-03-01
Form 8-K
ID: 0001723128-24-000007
2024-01-10
Form 8-K
ID: 0001723128-24-000003
2023-12-15
Form 8-K
ID: 0001193125-23-296658
2023-11-14
Form 8-K
ID: 0001193125-23-277184